Dear Sir, Xanthine oxidase-superoxide production has been implicated in the initiation of the peroxidative process in the myocardium under certain pathophysiological conditions [1]. In line with this hypothesis are reports which show that allopurinol [4-hydroxypyrazolo-(3,4d) pyrimidine], a xanthine oxidase inhibitor, can prevent or significantly reduce myocardial reperfusion injury [2]. In most of these studies, however, the doses of allopurinol required are very high, and in all cases, they are far above those used in humans for the treatment of gout. Different reports have shown that overdosing with allopurinol can exert certain toxic effects in the rat [3,4]. In a previous study [4] we have shown that chronic administration of allopurinol (20 mg/kg twice a day for 5 days) fails to exert any cardioprotective effect in rats submitted to permanent coronary artery ligation. Moreover, our results suggested the occurrence of a toxic effect of the treatment, as shown by an increase in tissue edema in the nonischemic portion of the myocardium in treated animals. In the present study we examined the effects of chronic administration of allopurinol (according to the protocol previously described [4]) on (1) myocardial malondialdehyde (MDA) content, taken as an index of lipid peroxidation, (2) superoxide dismutase (SOD) and catalase activities, which are the main enzymatic systems involved in the clearance of oxygen free radicals, and (3) xanthine oxidase activity, which is supposed to be inhibited by the treatment. The experiment was carried out on male adult Wistar rats (220-250 g). Allopurinol (Sigma Chemical Company), suspended in an aqueous solution of gum arabic (20 g/l), was administered orally at 20 mg/kg twice a day for 5 days. Control animals received a similar treatment using vehicle only (gum arabic at 2%). Volumes of administration were adjusted to 1 ml for 100 g body weight. On the last day of treatment, animals (n = 9/group) were anesthetized with sodium pentobarbital (40 mg/kg i.p., 1 ml/kg) and heparin was administered via a femoral vein (100 IU/100 g). The hearts were cut out and perfused via the aorta for 4 minutes to remove any blood from the vascular beds. The perfusate was a Krebs-Henseleit buffer (Ca 2÷ = 2.4 mM; K ÷ = 5.6 mM; glucose 11 mM) equilibrated with a gas mixture of 95% 02 and 5% C02 at 37°C, pH 7.4. Following this perfusion, the hearts were quickly frozen in liquid nitrogen. MDA myocardial content, as well as SOD, catalase, and xanthine oxidase activities, were measured using conventional assays (using the method of Ohkawa et al. [5] for MDA measurement, of Marklund [6] for SOD activity, of Beers and Sizer [7] for catalase activity, and of Sugiura et al. [8] for xanthine oxidase activity). Results were expressed as mean _+ standard error of the mean (SEM) and compared using Student's t test following analysis of variance by Fisher's test. Treatment with allopurinol is likely to be associated with stimulation of a peroxidative process, shown by the elevation of myocardial MDA content and by the increase of SOD and catalase activities. Moreover, the activity of xanthine oxidase that has the potential to generate superoxide anions appears paradoxically to be increased in the myocardium of treated animals. Allopurinol is both a substrate and an inhibitor of xanthine oxidase [9]; during the reaction it is transformed into alloxanthine (oxypurinol). This metabolite is itself an inhibitor of the enzyme and is slowly cleared by the kidney. Suzuki and Sudo [3] have reported an elevation of both MDA content and xanthine oxidase activity in the kidney of rats 3 days after the onset of treatment with allopurinol (100 mg/kg b.w./ day, per os). These authors suggested that allopurinol could lead, in the early phase of the treatment, to an elevation of superoxide anion production because of the oxidation of allopurinol to oxypurinol. In a second phase, oxypuriliol produced by the reaction could reach a sufficient level to inhibit the enzyme. However, there is still no experimental evidence showing that either longer durations of treatment with allopurinol or oxypurinol administration can lead to an inhibition of xanthine oxidase-dependent superoxide production. Thus, the mechanism of the toxic effect of allopurinol remains unclear. In the light of our results it appears that, in our experimental conditions, allopurinol toxicity might involve an overproduction of oxy